Cargando…
Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713958/ http://dx.doi.org/10.1007/s12325-014-0150-8 |
| _version_ | 1782410231905517568 |
|---|---|
| author | Yardley, Denise A. Noguchi, Shinzaburo Pritchard, Kathleen I. Burris, Howard A. Baselga, José Gnant, Michael Hortobagyi, Gabriel N. Campone, Mario Pistilli, Barbara Piccart, Martine Melichar, Bohuslav Petrakova, Katarina Arena, Francis P. Erdkamp, Frans Harb, Wael A. Feng, Wentao Cahana, Ayelet Taran, Tetiana Lebwohl, David Rugo, Hope S. |
| author_facet | Yardley, Denise A. Noguchi, Shinzaburo Pritchard, Kathleen I. Burris, Howard A. Baselga, José Gnant, Michael Hortobagyi, Gabriel N. Campone, Mario Pistilli, Barbara Piccart, Martine Melichar, Bohuslav Petrakova, Katarina Arena, Francis P. Erdkamp, Frans Harb, Wael A. Feng, Wentao Cahana, Ayelet Taran, Tetiana Lebwohl, David Rugo, Hope S. |
| author_sort | Yardley, Denise A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4713958 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47139582016-01-21 Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Yardley, Denise A. Noguchi, Shinzaburo Pritchard, Kathleen I. Burris, Howard A. Baselga, José Gnant, Michael Hortobagyi, Gabriel N. Campone, Mario Pistilli, Barbara Piccart, Martine Melichar, Bohuslav Petrakova, Katarina Arena, Francis P. Erdkamp, Frans Harb, Wael A. Feng, Wentao Cahana, Ayelet Taran, Tetiana Lebwohl, David Rugo, Hope S. Adv Ther Erratum Springer Healthcare 2014-09-11 2014 /pmc/articles/PMC4713958/ http://dx.doi.org/10.1007/s12325-014-0150-8 Text en © Springer Healthcare 2014 |
| spellingShingle | Erratum Yardley, Denise A. Noguchi, Shinzaburo Pritchard, Kathleen I. Burris, Howard A. Baselga, José Gnant, Michael Hortobagyi, Gabriel N. Campone, Mario Pistilli, Barbara Piccart, Martine Melichar, Bohuslav Petrakova, Katarina Arena, Francis P. Erdkamp, Frans Harb, Wael A. Feng, Wentao Cahana, Ayelet Taran, Tetiana Lebwohl, David Rugo, Hope S. Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title | Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title_full | Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title_fullStr | Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title_full_unstemmed | Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title_short | Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis |
| title_sort | erratum to: everolimus plus exemestane in postmenopausal patients with hr(+) breast cancer: bolero-2 final progression-free survival analysis |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713958/ http://dx.doi.org/10.1007/s12325-014-0150-8 |
| work_keys_str_mv | AT yardleydenisea erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT noguchishinzaburo erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT pritchardkathleeni erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT burrishowarda erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT baselgajose erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT gnantmichael erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT hortobagyigabrieln erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT camponemario erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT pistillibarbara erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT piccartmartine erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT melicharbohuslav erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT petrakovakatarina erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT arenafrancisp erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT erdkampfrans erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT harbwaela erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT fengwentao erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT cahanaayelet erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT tarantetiana erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT lebwohldavid erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis AT rugohopes erratumtoeverolimusplusexemestaneinpostmenopausalpatientswithhrbreastcancerbolero2finalprogressionfreesurvivalanalysis |